Expulsion of Implanon®

Journal of Family Planning and Reproductive Health Care

Volumn 33, Issue 3, 2007, Pages 211-

  Gwinnell, Emily ^a  

^a Northamptonshire Healthcare NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ETONOGESTREL; MEDROXYPROGESTERONE ACETATE; 3 KETO DESOGESTREL; 3-KETO-DESOGESTREL; CONTRACEPTIVE AGENT; DESOGESTREL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE DENSITY; CASE REPORT; CLINICAL FEATURE; CONTRACEPTIVE DEVICE; DEVICE REMOVAL; FAMILY PLANNING; FEMALE; HUMAN; INFLAMMATION; SKIN REDNESS; DRUG IMPLANT; FOREIGN BODY;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DEVICE REMOVAL; DRUG IMPLANTS; FEMALE; FOREIGN-BODY MIGRATION; HUMANS;

EID: 34447320253     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118907781004877     Document Type: Article

References (4)

1. Committee on Safety of Medicines. Updated Prescribing Advice on the Effect of Depo-Provera on Bones. London, UK: 18 November 2004. http://www.mhra.gov.uk/home/idcplg?ldcService=SS_GET_PAGE&useSecondary= true&ssDocName=CON1004262&ssTargetNodeld=221 [Accessed 24 July 2006].
2. Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 2005; 71: 306-308.
3. Evans R, Holman R, Lindsay E. Migration of Implanon: two case reports. J Fam Plann Reprod Health Care 2005; 31: 71-72.
4. Edwards JE, Moore A. Implanon: a review of clinical studies. Br J Fam Plann 1999; 24(4 Suppl.): 3-16.